News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

E-Z-EM (EZM) Reports First Quarter Results for Fiscal 2008



10/11/2007 12:59:57 PM

LAKE SUCCESS, N.Y.--(BUSINESS WIRE)--E-Z-EM, Inc. (NASDAQ:EZEM) today announced financial results for its fiscal 2008 first quarter. Highlights for the quarter ended September 1, 2007 and recent weeks included: Net sales from continuing operations of $33.0 million Earnings from continuing operations of $0.65 million, or $0.06 per diluted share Formal launch of the Company’s new EZ CHEMTM blood analyzer Addition of EmpowerMR® to group purchasing contract with Amerinet Receipt of approximately $12.5 million of follow-on orders for RSDLTM skin decontaminant from the U.S. Department of Defense (DoD), and transfer of 510(k) title for RSDL to E-Z-EM Announcement of favorable clinical results for virtual colonoscopy from the ACRIN II study

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES